In January 2023 Wyntra Holdings Ltd completed its acquisition of DHP Healthcare.
DHP Healthcare is a speciality pharmaceutical company operating in the UK focusing on the sales and marketing of ethical and ‘niche’ pharmaceuticals as well as ‘Over The Counter’ products. The company was originally founded in 1959 and following the acquisition by Wyntra, it is actively building its product portfolio.
Asset light business with regulatory licenses to operate in the UK.
Portfolio of 6 marketing authorisations.
Established supply chain and third-party logistics.
Established Quality Management system and PSMF.
MHRA authorised WDA.
We focus on the marketing and commercialisation of branded and ‘niche’ prescription and ‘Over The Counter’ products.
Contact us to discuss any of our products or services by calling on the number provided at the top of the page or by using the contact form.
BUSINESS PROFILE: DHP Healthcare is a speciality pharmaceutical company focusing on the marketing and commercialisation or branded and ‘niche’ prescription and ‘Over The Counter’ products. The company was originally founded in 1959 to market dental products and since this time has added additional products to it’s portfolio.
DHP Healthcare market and sell a range of products in the UK.
DHP Healthcare is looking to acquire, in-license or foster brands that enhance the product range.
OUR VISION: To be recognised as a leading pharmaceutical company with a wide range of niche pharmaceutical products meeting ongoing medical needs.
OUR MISSION: To be a valued pharmaceutical supplier to the NHS and international markets maintaining the continual supply of medicines with proven therapeutic value.